VRelax wins Prix Galien MedTech Innovation Award

VRelax won the prestigious Prix Galien Medtech Innovation Award on May 19. This prize is awarded to companies that introduce meaningful (medical) tools within healthcare. The jury praises the approach of VRelax because of continuous (clinical) research and validation of the effect of VRelax within the GGZ, Hospitals and ARBO. The jury also expresses its sincere admiration for VRelax and their ability to implement VR broadly in healthcare. A development that is certainly important in situations where increasingly vulnerable patients have to be cared for with fewer people.

READ PRESSRELEASE
READ JURY REPORT

De greatest recognition for our work!

In the Netherlands, the Galenus Medicines Award and the Galenus Research Award have been presented each year since 1992. In 2018, the MedTech Innovation Award was introduced. The MedTech Innovation Award rewards proven valuable innovations in healthcare for patient, informal caregiver and/or care provider. Which drug, which researcher or which innovative product wins the awards is determined by an independent expert jury, all with broad expertise in the disciplines to be judged. The jury members consist of scientists from various pharmaceutical and medical disciplines and representatives of (government) institutions.

PRIX GALIEN WEBSITE
WATCH VIDEO